
Cigna announced the acquisition of CarepathRx, a private‑equity‑backed pharmacy that supplies prescription drugs to roughly 10% of U.S. hospitals. The deal expands Cigna’s vertical integration in the pharmaceutical supply chain, complementing its earlier purchase of Express Scripts.

Japanese drugmaker Asahi Kasei announced it will acquire German biotech Aicuris for €780 million, gaining its antiviral therapy pritelivir targeting HSV. The deal expands Asahi Kasei's anti‑infectives portfolio and supports its goal of reaching JPY 300 billion in pharma sales by 2030.

GlaxoSmithKline (GSK) announced the acquisition of privately held 35Pharma, a developer of a pulmonary arterial hypertension drug. The cash deal is valued at just under $1 billion, expanding GSK’s pipeline in respiratory and immunology.